A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors

Clinical trial NCT06716619 · RECRUITING

Trial details

NCT number: NCT06716619
Sponsor: Guangzhou FineImmune Biotechnology Co., LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Tumor Associated Lymph Node T Cell Advanced Solid Tumor Immunotherapy Serplulimab Injection

Start date: 2025-02-13
Primary completion: 2026-12-19
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.